Glimepiride (40 mg)

admin — Wed, 18 Feb 2026 10:55:03 +0000

Overview: Daunorubicin 20 mg Injection is a prescription chemotherapy medicine containing Daunorubicin Hydrochloride (20 mg) used primarily in the treatment of acute leukemias including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Key Benefits: – Effective in treating acute leukemias – Inhibits cancer cell DNA replication – Used in induction chemotherapy protocols Composition: Daunorubicin Hydrochloride (20 mg) How It Works: Daunorubicin works by intercalating into DNA and inhibiting topoisomerase II, which prevents DNA replication and leads to cancer cell death. Usage Instructions: – Administered only by qualified healthcare professionals – Dosage and schedule depend on treatment protocol and patient condition – Not for self administration Side Effects: – Bone marrow suppression – Nausea, vomiting, hair loss – Cardiotoxicity with long term or high dose use Precautions: – Regular monitoring of heart function and blood counts is required – Increased risk of infection and bleeding – Avoid use during pregnancy and breastfeeding unless clearly advised Storage Instructions: – Store below 25°C, protect from light, do not freeze Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

Daunorubicin 20mg – Globalstar International

Glimepiride (40 mg)